S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 60 of 242

Issue Date	Title / Author(s) / Citation	File
2004-06	Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients Lee, June-Chul; Lee, Kyung-Mi; Kim, Dong-Wan; Heo, Dae Seog Journal of Immunology, Vol.172 No.12, pp.7335-7340	DOI
2007-10	Palliative chemotherapy for pulmonary pleomorphic carcinoma Bae, Hyun-Mi; Min, Hye Sook; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Lee, Jong-Seok; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.58 No.1, pp.112-115	DOI
2007-12	Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Kim, D. -W.; Kim, S. -Y.; Kim, H. -K.; Kim, S. -W.; Shin, S. W.; Kim, J. S.; Park, K.; Lee, M. Y.; Heo, D. S. Annals of Oncology, Vol.18 No.12, pp.2009-2014	DOI
2008-02	Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma Song, E. -K.; Kim, S. -Y.; Kim, T. M.; Lee, K. -W.; Yun, T.; Na, I. -I.; Shin, H.; Lee, S. H.; Kim, D. W.; Khwarg, S. I.; Heo, D. S. Annals of Oncology, Vol.19 No.2, pp.242-246	DOI
2008-03	Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer Cho, Yo-Han; Lee, Se Hoon; Kim, Dong-Wan; Wu, Hong-Gyun; Hah, J. Hun; Rhee, Chae-Seo; Sung, Myung-Whun; Kim, Kwang Hyun; Heo, Dae Soeg Head and Neck, Vol.30 No.3, pp.346-350	DOI
2008-06	Gemcitabine and Vinorelbine Combination Chemotherapy in Anthracycline- and Taxane-pretreated Advanced Breast Cancer Kim, Hye Jin; Kim, Jin-Soo; Seo, Myung-Deok; Oh, So-Yeon; Oh, Do Youn; Kim, Jee Hyun; 이세훈; Kim, Dong Wan; Im, Seock Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.40 No.2, pp.81-86
2008-12	Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients Lee, Jeong-Ok; Kim, Dae-Young; Lim, Joo Han; Seo, Myung-Deock; Yi, Hyeon Gyu; Kim, Yu Jung; Lee, Se-Hoon; Kim, Dong-Wan; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.62 No.3, pp.381-384	DOI
2009-05	Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: A retrospective analysis Han, Jung Ho; Park, Chul-Kee; Lee, Se-Hoon; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won Chemotherapy, Vol.55 No.3, pp.145-154	view file DOI
2009-08	Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma Koh, Y.; Kim, T. M.; Jeon, Y. K.; Kwon, T. -K.; Hah, J. H.; Lee, S. -H.; Kim, D. -W.; Wu, H. -G.; Rhee, C. -S.; Sung, M. -W.; Kim, C. W.; Kim, K. H.; Heo, D. S. Annals of Oncology, Vol.20 No.8, pp.1414-1419	DOI
2009-08	Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer Kim, Hee Jun; Kim, Yu Jung; Seo, Myung-Deok; Yi, Hyeon Gyu; Lee, Se-Hoon; Lee, Sang-Min; Kim, Dong-Wan; Yang, Seok-Chul; Lee, Choon-Taek; Lee, Jong Seok; Kim, Young-Whan; Heo, Dae Seog Lung Cancer, Vol.65 No.2, pp.242-246	DOI
2009-08	Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin Park, Chul-Kee; Park, Sung-Hye; Lee, Se-Hoon; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won Neuropathology, Vol.29 No.4, pp.443-449	DOI
2009-10	Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma Kim, W. Y.; Jeon, Y. K.; Kim, T. M.; Kim, J. E.; Kim, Y. A.; Lee, S. -H.; Kim, D. -W.; Heo, D. S.; Kim, C. -W. Annals of Oncology, Vol.20 No.10, pp.1688-1696	DOI
2009-11	Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and beta III-Tubulin Between Primary Non-small Cell Lung Cancer and Metastatic Lymph Nodes and the Significance in Mid-Term Survival Kang, Chang Hyun; Jang, Bo Gun; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Jheon, Sanghoon; Sung, Sook-Whan; Kim, Joo Hyun Journal of Thoracic Oncology, Vol.4 No.11, pp.1307-1312	DOI
2009-12	Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy Park, Chul-Kee; Lee, Se-Hoon; Han, Jung Ho; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won BMC Cancer, Vol.9, p. 450	view file DOI
2010-02	Timing of local and distant failure in resected lung cancer: Implications for reported rates of local failure Boyd, Jessamy A.; Hubbs, Jessica L.; Kim, Dong W.; Hollis, Donna; Marks, Lawrence B.; Kelsey, Chris R. Journal of Thoracic Oncology, Vol.5 No.2, pp.211-214	DOI
2010-03	An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity Hartman, Zachary C.; Wei, Junping; Osada, Takuya; Glass, Oliver; Lei, Gangjun; Yang, Xiao-Yi; Peplinski, Sharon; Kim, Dong-Wan; Xia, Wenle; Spector, Neil; Marks, Jeffrey; Barry, William; Hobeika, Amy; Devi, Gayathri; Amalfitano, Andrea; Morse, Michael A.; Lyerly, H. Kim; Clay, Timothy M. Clinical Cancer Research, Vol.16 No.5, pp.1466-1477	DOI
2010-05	First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors Kim, Tae Min; Kim, Ki Hwan; Lee, Min Joung; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Chul Woo; Kim, Il Han; Khwarg, Sang In; Heo, Dae Seog Cancer Science, Vol.101 No.5, pp.1199-1203	view file DOI
2010-06	The prognostic significance of ERCC1, BRCA1, XRCC1, and beta 111-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection Kang, Chang Hyun; Jang, Bo Gun; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Jheon, Sanghoon; Sung, Sook-Whan; Kim, Joo Hyun Lung Cancer, Vol.68 No.3, pp.478-483	DOI
2010-06	Definitive Radiotherapy With or Without Chemotherapy for T3-4N0 Squamous Cell Carcinoma of the Maxillary Sinus and Nasal Cavity Jang, Na Young; Wu, Hong-Gyun; Park, Charn Il; Heo, Dae-Seog; Kim, Dong-Wan; Lee, Se-Hoon; Rhee, Chae-Seo Japanese Journal of Clinical Oncology, Vol.40 No.6, pp.542-548	DOI
2011-01	A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinonna harboring EGFR mutations Kim, Dong-Wan; Lee, Se-Hoon; Lee, Jong Seok; Lee, Myung Ah; Kang, Jin Hyoung; Kim, Si Young; Shin, Sang Won; Kim, Hoon-Kyo; Heo, Dae Seog Lung Cancer, Vol.71 No.1, pp.65-69	DOI
2011-04	EGFR Gene Copy Number Gain is Related to High Tumor SUV and Frequent Relapse after Adjuvant Chemotherapy in Resected Lung Adenocarcinoma Koh, Youngil; Jang, Bogun; Jeon, Yoon Kyung; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Japanese Journal of Clinical Oncology, Vol.41 No.4, pp.548-554	DOI
2011-07	Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial Kim, Il Han; Park, Chul-Kee; Heo, Dae Seog; Kim, Chae-Yong; Rhee, Chang Hun; Nam, Do-Hyun; Lee, Seung Hoon; Han, Jung Ho; Lee, Se-Hoon; Kim, Tae Min; Kim, Dong-Wan; Kim, Jeong Eun; Paek, Sun Ha; Kim, Dong Gyu; Kim, In Ah; Kim, Yu Jung; Kim, Jee Hyun; Park, Byung-Joo; Jung, Hee-Won Journal of Neuro-Oncology, Vol.103 No.3, pp.595-602	DOI
2011-08	Pulmonary Artery Sarcoma Detected on F-18 FDG PET/CT as Origin of Multiple Spinal Metastases Chun, In Kook; Eo, Jae Seon; Paeng, Jin Chul; Kim, Dong Wan; Chung, June-Key; Lee, Dong Soo Clinical Nuclear Medicine, Vol.36 No.8, pp.E87-E89	DOI
2011-08	Clinical dissection of multicentric Castleman disease Shin, Dong-Yeop; Jeon, Yoon Kyung; Hong, Yong-Sang; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Inho; Yoon, Sung-Soo; Heo, Dae Seog; Park, Seonyang; Kim, Byoung Kook Leukemia and Lymphoma, Vol.52 No.8, pp.1517-1522	DOI
2011-11	Clinical significance of tumor-infiltrating FOXP3+T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma Kim, Ki Hwan; Kim, Tae Min; Go, Heounjeong; Kim, Wook Youn; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Khwarg, Sang In; Kim, Chul-Woo; Heo, Dae Seog Cancer Science, Vol.102 No.11, pp.1972-1976	view file DOI
2012-02	Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer Sim, Sung Hoon; Ahn, Yong-Oon; Yoon, Jieun; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Cancer Science, Vol.103 No.2, pp.155-160	view file DOI
2012-03	Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients Kang, Hyo Jae; Park, Jong Sun; Kim, Dong-Wan; Lee, Jinwoo; Jeong, Yun Jeong; Choi, Sun Mi; Lee, Sang-Min; Yang, Seok-Chul; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Yim, Jae-Joon Respiratory Medicine, Vol.106 No.3, pp.443-450	DOI
2012-05	Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial van der Graaf, Winette T. A.; Blay, Jean-Yves; Chawla, Sant P.; Kim, Dong-Wan; Binh Bui-Nguyen; Casali, Paolo G.; Schoffski, Patrick; Aglietta, Massimo; Staddon, Arthur P.; Beppu, Yasuo; Le Cesne, Axel; Gelderblom, Hans; Judson, Ian R.; Araki, Nobuhito; Ouali, Monia; Marreaud, Sandrine; Hodge, Rachel; Dewji, Mohammed R.; Coens, Corneel; Demetri, George D.; Fletcher, Christopher D.; Tos, Angelo Paolo Dei; Hohenberger, Peter The Lancet, Vol.379 No.9829, pp.1879-1886	DOI
2012-08	Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients Park, Heae Surng; Lee, June Koo; Kim, Dong-Wan; Kulig, Kimary; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Heo, Dae Seog Lung Cancer, Vol.77 No.2, pp.288-292	DOI
2012-08	EGFR mutations as a predictive marker of cytotoxic chemotherapy Park, Jin Hyun; Lee, Se-Hoon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.77 No.2, pp.433-437	DOI
2012-09	Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis Bae, Hyun-Mi; Lee, Se-Hoon; Kim, Tae Min; Kim, Dong-Wan; Yang, Seok-Chul; Wu, Hong Gyun; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.77 No.3, pp.572-577	DOI
2012-12	Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer Koo, Tae Ryool; Wu, Hong-Gyun; Hah, J. Hun; Sung, Myung-Whun; Kim, Kwang-Hyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae-Seog; Park, Charn Il Cancer Research and Treatment, Vol.44 No.4, pp.227-234	view file DOI
2012-12	Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients Lee, Joo Ho; Wu, Hong-Gyun; Kim, Hak Jae; Kim, Dong-Wan; Lee, Se-Hoon; Kim, Tae Min; Kim, Young Whan; Heo, Dae Seog Cancer Research and Treatment, Vol.44 No.4, pp.242-250	view file DOI
2013-01	Surrogate decision-making in Korean patients with advanced cancer: a longitudinal study Lee, June Koo; Keam, Bhumsuk; An, Ah Reum; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Supportive Care in Cancer, Vol.21 No.1, pp.183-190	DOI
2013-01	Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer Lira, Maruja E.; Kim, Tae Min; Huang, Donghui; Deng, Shibing; Koh, Youngil; Jang, Bogun; Go, Heounjeong; Lee, Se-Hoon; Chung, Doo Hyun; Kim, Woo Ho; Schoenmakers, Eric F. P. M.; Choi, Yoon-La; Park, Keunchil; Ahn, Jin Seok; Sun, Jong-Mu; Ahn, Myung-Ju; Kim, Dong-Wan; Mao, Mao Journal of Molecular Diagnostics, Vol.15 No.1, pp.51-61	DOI
2013-01	Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis Lee, J.; Hahn, S.; Kim, D. -W.; Kim, J.; Kang, S. N.; Rha, S. Y.; Lee, K. B.; Kang, J. -H.; Park, B. -J. British Journal of Cancer, Vol.108 No.1, pp.39-48	DOI
2013-03	Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT Choi, Hongyoon; Paeng, Jin Chul; Kim, Dong-Wan; Lee, June Koo; Park, Chang Min; Kang, Keon Wook; Chung, June-Key; Lee, Dong Soo Lung Cancer, Vol.79 No.3, pp.242-247	DOI
2013-03	Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma Kim, Tae Min; Paeng, Jin Chul; Chun, In Kook; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Dong Soo; Kim, Chul Woo; Chung, June-Key; Kim, Il Han; Heo, Dae Seog Cancer, Vol.119 No.6, pp.1195-1202	DOI
2013-03	Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer Lee, Joo Ho; Wu, Hong-Gyun; Kim, Hak jae; Park, Charn Il; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Radiation Oncology Journal, Vol.31 No.1, pp.18-24	view file DOI
2013-03	Predictive markers for neoadjuvant chemotherapy in advanced squamous cell carcinoma of maxillary sinus: Preliminary report Choi, Ik Joon; Kim, Dong-Wan; Kim, Dong-Young; Lee, Chul Hee; Rhee, Chae-Seo Acta Oto-Laryngologica, Vol.133 No.3, pp.291-296	DOI
2013-04	Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer Kim, Soyeon; Kim, Tae Min; Kim, Dong-Wan; Go, Heounjeong; Keam, Bhumsuk; Lee, Se-Hoon; Ku, Ja-Lok; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.8 No.4, pp.415-422	DOI
2013-06	Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer Shaw, Alice T.; Kim, Dong-Wan; Nakagawa, Kazuhiko; Seto, Takashi; Crino, Lucio; Ahn, Myung-Ju; De Pas, Tommaso; Besse, Benjamin; Solomon, Benjamin J.; Blackhall, Fiona; Wu, Yi-Long; Thomas, Michael; O'Byrne, Kenneth J.; Moro-Sibilot, Denis; Camidge, D. Ross; Mok, Tony; Hirsh, Vera; Riely, Gregory J.; Iyer, Shrividya; Tassell, Vanessa; Polli, Anna; Wilner, Keith D.; Jaenne, Pasi A. New England Journal of Medicine, Vol.368 No.25, pp.2385-2394	DOI
2013-07	Tumor Burden is Predictive of Survival in Patients With Non-Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib Park, Jin Hyun; Kim, Tae Min; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Clinical Lung Cancer, Vol.14 No.4, pp.383-389	DOI
2013-07	Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy Lim, Yoojoo; Keam, Bhumsuk; Koh, Youngil; Kim, Tae Min; Lee, Se-Hoon; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog; Kim, Kwang Hyun Oral Surgery Oral Medicine Oral Pathology Oral Radiology, Vol.116 No.1, pp.55-60	DOI
2013-08	Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study Lee, J. K.; Shin, J. -Y.; Kim, S.; Lee, S.; Park, C.; Kim, J. -Y.; Koh, Y.; Keam, B.; Min, H. S.; Kim, T. M.; Jeon, Y. -K.; Kim, D. -W.; Chung, D. H.; Heo, D. S.; Lee, S. -H.; Kim, J. -I. Annals of Oncology, Vol.24 No.8, pp.2080-2087	DOI
2013-08	Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non-Small-Cell Lung Cancer Lee, Eunyoung; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.8 No.8, pp.1069-1074	DOI
2013-09	How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.45 No.3, pp.178-185	view file DOI
2013-09	Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment Huang, Donghui; Kim, Dong-Wan; Kotsakis, Athanasios; Deng, Shibing; Lira, Paul; Ho, Steffan N.; Lee, Nathan V.; Vizcarra, Pamela; Cao, Joan Q.; Christensen, James G.; Kim, Tae Min; Sun, Jong-mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Mao, Mao Genomics, Vol.102 No.3, pp.157-162	DOI
2014-01	A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy Lee, Hee Yeon; Kim, Hoon-Kyo; Lee, Kyung Hee; Kim, Bong-Seog; Song, Hong Suk; Yang, Sung Hyun; Kim, Joon Hee; Kim, Yeul Hong; Kim, Jong Gwang; Kim, Sang-We; Kim, Dong-Wan; Kim, Si-Young; Park, Hee Sook Cancer Research and Treatment, Vol.46 No.1, pp.19-26	view file DOI
2014-02	Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC Ou, Sai-Hong I.; Jaenne, P. A.; Bartlett, C. H.; Tang, Y.; Kim, D. -W.; Otterson, G. A.; Crino, L.; Selaru, P.; Cohen, D. P.; Clark, J. W.; Riely, G. J. Annals of Oncology, Vol.25 No.2, pp.415-422	DOI
2014-03	Clinical Significance of Downstaging in Patients With Limited-Disease Small-Cell Lung Cancer Go, Se-Il; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Hak Jae; Wu, Hong-Gyun; Chung, Doo Hyun; Heo, Dae Seog Clinical Lung Cancer, Vol.15 No.2, pp.E1-E6	DOI
2014-03	Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer Shaw, Alice T.; Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S. W.; Felip, Enriqueta; Chow, Laura Q. M.; Camidge, D. Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J.; Solomon, Benjamin J.; Wolf, Juergen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Lau, Yvonne Y.; Goldwasser, Meredith; Boral, Anthony L.; Engelman, Jeffrey A. New England Journal of Medicine, Vol.370 No.13, pp.1189-1197	DOI
2014-04	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non-Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor A Meta-analysis Lee, June-Koo; Hahn, Seokyung; Kim, Dong-Wan; Suh, Koung Jin; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog JAMA - Journal of the American Medical Association, Vol.311 No.14, pp.1430-1437	DOI
2014-04	Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma Kim, Tae Min; Kim, Soyeon; Ahn, Yong-Oon; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Leukemia and Lymphoma, Vol.55 No.4, pp.940-943	DOI
2014-06	Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer Lee, Yun-Gyoo; Kim, Inho; Lee, Eunyoung; Bang, Soo-Mee; Kang, Chang Hyun; Kim, Young Tae; Kim, Hak Jae; Wu, Hong-Gyun; Kim, Young Whan; Kim, Tae Min; Lee, Keun-Wook; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Thrombosis and Haemostasis, Vol.111 No.6, pp.1112-1120	view file DOI
2014-08	ALK Molecular Phenotype in Non-Small Cell Lung Cancer: CT Radiogenomic Characterization Yamamoto, Shota; Korn, Ronald L.; Oklu, Rahmi; Migdal, Christopher; Gotway, Michael B.; Weiss, Glen J.; Iafrate, A. John; Kim, Dong-Wan; Kuo, Michael D. Radiology, Vol.272 No.2, pp.568-576	DOI
2014-08	Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog International Journal of Clinical Oncology, Vol.19 No.4, pp.594-600	DOI
2014-08	The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: A retrospective cohort study Shin, Dong-Yeop; Kim, Dong-Wan; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kang, Chang Hyun; Kim, Young Tae; Heo, Dae Seog Lung Cancer, Vol.85 No.2, pp.320-325	DOI
2014-09	First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial Yang, James Chih-Hsin; Kang, Jin Hyoung; Mok, Tony; Ahn, Myung-Ju; Srimuninnimit, Vichien; Lin, Chia-Chi; Kim, Dong-Wan; Tsai, Chun-Ming; Barraclough, Helen; Altug, Sedat; Orlando, Mauro; Park, Keunchil European Journal of Cancer, Vol.50 No.13, pp.2219-2230	DOI
2014-09	AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer Cross, Darren A. E.; Ashton, Susan E.; Ghiorghiu, Serban; Eberlein, Cath; Nebhan, Caroline A.; Spitzler, Paula J.; Orme, Jonathon P.; Finlay, M. Raymond V.; Ward, Richard A.; Mellor, Martine J.; Hughes, Gareth; Rahi, Amar; Jacobs, Vivien N.; Brewer, Monica Red; Ichihara, Eiki; Sun, Jing; Jin, Hailing; Ballard, Peter; Al-Kadhimi, Katherine; Rowlinson, Rachel; Klinowska, Teresa; Richmond, Graham H. P.; Cantarini, Mireille; Kim, Dong-Wan; Ranson, Malcolm R.; Pao, William Cancer Discovery, Vol.4 No.9, pp.1046-1061	DOI

1 2 3 4 5